Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

720 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma.
Mittlmeier LM, Unterrainer M, Todica A, Cyran CC, Rodler S, Bartenstein P, Stief CG, Ilhan H, Staehler M. Mittlmeier LM, et al. Among authors: bartenstein p. Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2216-2217. doi: 10.1007/s00259-019-04636-6. Epub 2020 Jan 11. Eur J Nucl Med Mol Imaging. 2020. PMID: 31925458 No abstract available.
Imaging of lung cancer with fluorine-18 fluorodeoxyglucose: comparison of a dual-head gamma camera in coincidence mode with a full-ring positron emission tomography system.
Weber WA, Neverve J, Sklarek J, Ziegler SI, Bartenstein P, King B, Treumann T, Enterrottacher A, Krapf M, Häussinger KE, Lichte H, Präuer HW, Thetter O, Schwaiger M. Weber WA, et al. Among authors: bartenstein p. Eur J Nucl Med. 1999 Apr;26(4):388-95. doi: 10.1007/s002590050402. Eur J Nucl Med. 1999. PMID: 10199945 Clinical Trial.
The dopamine D2 receptor ligand 18F-desmethoxyfallypride: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism.
Schreckenberger M, Hägele S, Siessmeier T, Buchholz HG, Armbrust-Henrich H, Rösch F, Gründer G, Bartenstein P, Vogt T. Schreckenberger M, et al. Among authors: bartenstein p. Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1128-35. doi: 10.1007/s00259-004-1465-5. Epub 2004 Mar 23. Eur J Nucl Med Mol Imaging. 2004. PMID: 15042325 Clinical Trial.
720 results